Audhya Paul K. 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Audhya Paul K.（CIK 1860131）在 1 家公司共报告 31 笔 SEC Form 4 内部人交易（最近一笔 2026-06-11）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-06-11 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | 卖出 | 150,260 | $0 |
| 2026-05-27 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | 买入 | 5,000 | $0 |
| 2026-05-27 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | 卖出 | 2,239 | $59,960 |
| 2026-05-26 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | 买入 | 6,250 | $0 |
| 2026-05-26 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | 卖出 | 2,685 | $71,904 |
| 2026-05-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | 买入 | 2,419 | $0 |
| 2026-05-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | 卖出 | 1,032 | $27,616 |
| 2026-04-20 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | 买入 | 6,250 | $0 |
| 2026-04-20 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | 卖出 | 2,686 | $54,311 |
| 2026-02-24 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | 买入 | 6,250 | $0 |
| 2026-02-24 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | 买入 | 5,000 | $0 |
| 2026-02-24 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | 卖出 | 5,354 | $83,362 |
| 2026-02-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | 买入 | 2,419 | $0 |
| 2026-02-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | 卖出 | 1,163 | $17,445 |
| 2025-11-26 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | 买入 | 6,250 | $0 |
| 2025-11-26 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | 买入 | 5,000 | $0 |
| 2025-11-26 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | 卖出 | 5,296 | $71,231 |
| 2025-11-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | 买入 | 6,447 | $0 |
| 2025-11-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | 卖出 | 3,075 | $44,526 |
| 2025-08-26 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | 买入 | 5,000 | $0 |
| 2025-08-26 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | 卖出 | 2,336 | $31,349 |
| 2025-08-25 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | 买入 | 6,250 | $0 |
| 2025-08-25 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | 卖出 | 2,942 | $38,893 |
| 2025-08-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | 买入 | 6,446 | $0 |
| 2025-08-19 | KalVista Pharmaceuticals, Inc. (KALV) | CHIEF MEDICAL OFFICER | 卖出 | 2,939 | $38,765 |
来源：SEC Form 4 申报文件 · 截至 2026-06-11